Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIELD: Bivalent HPV Vaccine in Infants, Toddlers, Children and Young Females in Ghana
NCT07377656Phase 2Recruiting
- Sponsor
- International Vaccine Institute
- Start
- Apr 2026
- Primary completion
- Feb 2028
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human papillomavirus bivalent (types 16, 18) vaccine in human papillomavirus infection, sponsored by International Vaccine Institute. Started Apr 2026; status: recruiting.
02
Drugs
recombinant human papillomavirus bivalent (types 16, 18) vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT07377656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07377656.